The relation between gouty arthritis and menopause: A Unani conceptual review

Abstract

Menopausal stages are progressively associated with an increased prevalence of hyperuricemia, especially from the late transition stage. This association was independent of age and other confounders, indicating menopausal stage per se as an independent risk factor for hyperuricemia. Estrogen has uricosuric properties and with its decline the menopausal women are prone to gouty arthritis. Hormone replacement therapy is touted as the best treatment to problem of gout in menopause. However, HRT isn’t without risks. In fact, it has been linked to an increased risk of breast cancer, heart disease, osteoporosis and stroke. The side effect of the therapy shows immense responsibility of the alternative medicine to create awareness for the particular aspect. Unani medicine has a variety of safe and effective drugs for the management of Niqris(Gout) in Menopause. And it has been successful in treating this disease since a long time without any unwanted effects.